Skip to content
Home/Companies/HealthTech/R2I D* Softway Medical Developpement
R2I D* Softway Medical Developpement

R2I D* Softway Medical Developpement

HealthTech·France·Exited 2020·Held 3yr
Entry
2017
Hold
3yr
Exit
2020

Who owns R2I D* Softway Medical Developpement?

R2I D* Softway Medical Developpement is a French HealthTech company, formerly owned by Naxicap Partners, exited in 2020 (exit via MBO). No current private equity owner is on file.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Naxicap Partners
Investor
Naxicap Partners
NIO I · 2017 · Buyout

Key facts

HQFrance
SectorHealthTech
Websitewww.groupesoftwaymedical.com
Exit Type
MBO
Buyer
Santorin Participations
Exit Year
2020

More from NIO I

Other portfolio companies in the same fund.

Dental Monitoring
Dental Monitoring
Exited 2021
HealthTechFrance· 2019
to Merieux Equity Partners / Vitruvian Partners
Emera
Active
HealthcareFrance· 2019
Executive IT
Exited 2023
IT ServicesFrance· 2019
to Bechtle AG
Finophta
Exited 2019
SoftwareFrance· 2019
to EYE-Q
KEYS ASSET MANAGEMENT
Keys Asset Management
Active
Business ServicesFrance· 2019
MORIA
Moria
Active
MedTechFrance· 2019

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns R2I D* Softway Medical Developpement?

R2I D* Softway Medical Developpement was formerly owned by Naxicap Partners, exited in 2020. No current private equity owner is on file.

Who did R2I D* Softway Medical Developpement sell to?

Naxicap Partners sold R2I D* Softway Medical Developpement to Santorin Participations in 2020 (MBO).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue